Financials

Takeda Pharmaceutical: FYE Mar 2026 and ten years of results (46 metrics)

FYE Mar 2026 · Revenue¥4.51tnYoY −1.7%
FYE Mar 2026 · Operating profit¥6.2bnYoY −98.2%
FYE Mar 2026 · Net profit-¥152bnYoY −241.2%
FYE Mar 2025 · Equity ratio48.7%YoY +0.5pp
FYE Mar 2026 · Group employees47,029YoY −426
Fiscal yearRevenueYoYOperating profitYoYMarginNet profitChief executiveThat year
FYE Mar 2017Consolidated¥1.73tnn/an/an/an/a¥115bnChristophe Weber
FYE Mar 2018Consolidated¥1.77tn+2.2%¥242bnn/a13.7%¥187bnChristophe WeberARIAD Pharmaceuticals acquired by tender offer
FYE Mar 2019Consolidated¥2.10tn+18.5%¥238bn−1.7%11.3%¥135bnChristophe WeberAmerican depositary shares listed on the New York Stock Exchange
FYE Mar 2020Consolidated¥3.29tn+56.9%¥100bn−57.8%3.1%¥44bnChristophe WeberShire acquired for about ¥6.8 trillion
FYE Mar 2021Consolidated¥3.20tn−2.8%¥509bn+407.2%15.9%¥376bnChristophe WeberConsolidated revenue reaches ¥3,291.2 billion
FYE Mar 2022Consolidated¥3.57tn+11.6%¥461bn−9.5%12.9%¥230bnChristophe Weber
FYE Mar 2023Consolidated¥4.03tn+12.8%¥491bn+6.4%12.2%¥317bnChristophe Weber
FYE Mar 2024Consolidated¥4.26tn+5.9%¥214bn−56.4%5.0%¥144bnChristophe Weber
FYE Mar 2025Consolidated¥4.58tn+7.5%¥343bn+60.0%7.5%¥108bnChristophe WeberRestructuring costing ¥140 billion a year announced
FYE Mar 2026Consolidated¥4.51tn−1.7%¥6.2bn−98.2%0.1%-¥152bnChristophe Weber

How it compares

Income statement Revenue, costs, each level of profit and the margins they leave

Where the revenue goes

¥ bn
Cost of sales SG&A Other operating costs Operating profit

Margins

%
Gross margin Operating margin Net margin

Revenue net sales, operating revenue

FYE Mar 2026 ¥4.51tn
CAGR · 10 yrs +11.2%
Fiscal year Revenue ¥ bn YoY Basis
FYE Mar 2017 1,732 n/a Cons. · IFRS
FYE Mar 2018 1,771 +2.2% Cons. · IFRS
FYE Mar 2019 2,097 +18.5% Cons. · IFRS
FYE Mar 2020 3,291 +56.9% Cons. · IFRS
FYE Mar 2021 3,198 −2.8% Cons. · IFRS
FYE Mar 2022 3,569 +11.6% Cons. · IFRS
FYE Mar 2023 4,027 +12.8% Cons. · IFRS
FYE Mar 2024 4,264 +5.9% Cons. · IFRS
FYE Mar 2025 4,582 +7.5% Cons. · IFRS
FYE Mar 2026 4,506 −1.7% Cons. · IFRS
Definition
Everything the company took in from its own business
Formula
Revenue line of the income statement
Source
Securities report (XBRL)

Cost of sales

FYE Mar 2026 ¥1.57tn
CAGR · 9 yrs +15.5%
Fiscal year Cost of sales ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 496 n/a Cons. · IFRS
FYE Mar 2019 652 +31.4% Cons. · IFRS
FYE Mar 2020 1,090 +67.2% Cons. · IFRS
FYE Mar 2021 994 −8.8% Cons. · IFRS
FYE Mar 2022 1,107 +11.3% Cons. · IFRS
FYE Mar 2023 1,244 +12.4% Cons. · IFRS
FYE Mar 2024 1,427 +14.7% Cons. · IFRS
FYE Mar 2025 1,580 +10.8% Cons. · IFRS
FYE Mar 2026 1,572 −0.5% Cons. · IFRS
Definition
The cost of what was sold
Formula
Cost of sales line of the income statement
Source
Securities report (XBRL)

Gross profit

FYE Mar 2026 ¥2.93tn
CAGR · 9 yrs +11.0%
Fiscal year Gross profit ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 1,275 n/a Cons. · IFRS
FYE Mar 2019 1,445 +13.4% Cons. · IFRS
FYE Mar 2020 2,201 +52.3% Cons. · IFRS
FYE Mar 2021 2,204 +0.1% Cons. · IFRS
FYE Mar 2022 2,462 +11.7% Cons. · IFRS
FYE Mar 2023 2,783 +13.0% Cons. · IFRS
FYE Mar 2024 2,837 +1.9% Cons. · IFRS
FYE Mar 2025 3,001 +5.8% Cons. · IFRS
FYE Mar 2026 2,934 −2.2% Cons. · IFRS
Definition
What the product or service itself earns
Formula
Revenue − cost of sales
Source
Securities report (XBRL)

SG&A selling, general and administrative expenses

FYE Mar 2026 ¥1.08tn
CAGR · 9 yrs +7.1%
Fiscal year SG&A ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 628 n/a Cons. · IFRS
FYE Mar 2019 718 +14.2% Cons. · IFRS
FYE Mar 2020 965 +34.4% Cons. · IFRS
FYE Mar 2021 876 −9.2% Cons. · IFRS
FYE Mar 2022 886 +1.2% Cons. · IFRS
FYE Mar 2023 997 +12.5% Cons. · IFRS
FYE Mar 2024 1,054 +5.7% Cons. · IFRS
FYE Mar 2025 1,105 +4.8% Cons. · IFRS
FYE Mar 2026 1,084 −1.9% Cons. · IFRS
Definition
The cost of selling and of running the company
Formula
SG&A line of the income statement
Source
Securities report (XBRL)

Operating profit

FYE Mar 2026 ¥6.2bn
CAGR · 9 yrs −36.7%
Fiscal year Operating profit ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 242 n/a Cons. · IFRS
FYE Mar 2019 238 −1.7% Cons. · IFRS
FYE Mar 2020 100 −57.8% Cons. · IFRS
FYE Mar 2021 509 +407.2% Cons. · IFRS
FYE Mar 2022 461 −9.5% Cons. · IFRS
FYE Mar 2023 491 +6.4% Cons. · IFRS
FYE Mar 2024 214 −56.4% Cons. · IFRS
FYE Mar 2025 343 +60.0% Cons. · IFRS
FYE Mar 2026 6.2 −98.2% Cons. · IFRS
Definition
What the core business earns
Formula
Gross profit − SG&A
Source
Securities report (XBRL)

Non-operating income

FYE Mar 2026 ¥211bn
CAGR · 9 yrs +23.3%
Fiscal year Non-operating income ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 39.5 n/a Cons. · IFRS
FYE Mar 2019 16.8 −57.4% Cons. · IFRS
FYE Mar 2020 27.8 +65.2% Cons. · IFRS
FYE Mar 2021 106 +279.1% Cons. · IFRS
FYE Mar 2022 23.7 −77.5% Cons. · IFRS
FYE Mar 2023 62.9 +165.5% Cons. · IFRS
FYE Mar 2024 52.1 −17.2% Cons. · IFRS
FYE Mar 2025 46.5 −10.6% Cons. · IFRS
FYE Mar 2026 211 +353.7% Cons. · IFRS
Definition
Income from outside the core business
Formula
Non-operating income line of the income statement
Source
Securities report (XBRL)

Non-operating expenses

FYE Mar 2026 ¥358bn
CAGR · 9 yrs +35.3%
Fiscal year Non-operating expenses ¥ bn YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 31.9 n/a Cons. · IFRS
FYE Mar 2019 83.3 +160.9% Cons. · IFRS
FYE Mar 2020 165 +98.1% Cons. · IFRS
FYE Mar 2021 249 +50.7% Cons. · IFRS
FYE Mar 2022 167 −33.0% Cons. · IFRS
FYE Mar 2023 170 +1.9% Cons. · IFRS
FYE Mar 2024 220 +29.6% Cons. · IFRS
FYE Mar 2025 210 −4.5% Cons. · IFRS
FYE Mar 2026 358 +70.2% Cons. · IFRS
Definition
Costs arising outside the core business
Formula
Non-operating expenses line of the income statement
Source
Securities report (XBRL)

Net profit profit attributable to owners of the parent

FYE Mar 2026 -¥152bn
Average · 10 yrs ¥150bn
Fiscal year Net profit ¥ bn YoY Basis
FYE Mar 2017 115 n/a Cons. · IFRS
FYE Mar 2018 187 +62.6% Cons. · IFRS
FYE Mar 2019 135 −27.7% Cons. · IFRS
FYE Mar 2020 44.2 −67.3% Cons. · IFRS
FYE Mar 2021 376 +749.9% Cons. · IFRS
FYE Mar 2022 230 −38.8% Cons. · IFRS
FYE Mar 2023 317 +37.8% Cons. · IFRS
FYE Mar 2024 144 −54.6% Cons. · IFRS
FYE Mar 2025 108 −25.1% Cons. · IFRS
FYE Mar 2026 -152 −241.2% Cons. · IFRS
Definition
What is left after tax
Formula
Pre-tax profit − income taxes
Source
Securities report (XBRL)

Gross margin

FYE Mar 2026 65.1%
Average · 9 yrs 68.0%
Fiscal year Gross margin % YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 72.0 n/a Cons. · IFRS
FYE Mar 2019 68.9 −3.1pp Cons. · IFRS
FYE Mar 2020 66.9 −2.0pp Cons. · IFRS
FYE Mar 2021 68.9 +2.0pp Cons. · IFRS
FYE Mar 2022 69.0 +0.1pp Cons. · IFRS
FYE Mar 2023 69.1 +0.1pp Cons. · IFRS
FYE Mar 2024 66.5 −2.6pp Cons. · IFRS
FYE Mar 2025 65.5 −1.0pp Cons. · IFRS
FYE Mar 2026 65.1 −0.4pp Cons. · IFRS
Definition
The share of revenue left after the cost of sales
Formula
Gross profit ÷ revenue
Source
Securities report (XBRL)

Operating margin

FYE Mar 2026 0.1%
Average · 9 yrs 9.1%
Fiscal year Operating margin % YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 13.7 n/a Cons. · IFRS
FYE Mar 2019 11.3 −2.3pp Cons. · IFRS
FYE Mar 2020 3.1 −8.3pp Cons. · IFRS
FYE Mar 2021 15.9 +12.9pp Cons. · IFRS
FYE Mar 2022 12.9 −3.0pp Cons. · IFRS
FYE Mar 2023 12.2 −0.7pp Cons. · IFRS
FYE Mar 2024 5.0 −7.2pp Cons. · IFRS
FYE Mar 2025 7.5 +2.5pp Cons. · IFRS
FYE Mar 2026 0.1 −7.3pp Cons. · IFRS
Definition
The share of revenue the core business keeps
Formula
Operating profit ÷ revenue
Source
Securities report (XBRL)

Net margin

FYE Mar 2026 -3.4%
Average · 10 yrs 5.3%
Fiscal year Net margin % YoY Basis
FYE Mar 2017 6.6 n/a Cons. · IFRS
FYE Mar 2018 10.6 +3.9pp Cons. · IFRS
FYE Mar 2019 6.4 −4.1pp Cons. · IFRS
FYE Mar 2020 1.3 −5.1pp Cons. · IFRS
FYE Mar 2021 11.8 +10.4pp Cons. · IFRS
FYE Mar 2022 6.4 −5.3pp Cons. · IFRS
FYE Mar 2023 7.9 +1.4pp Cons. · IFRS
FYE Mar 2024 3.4 −4.5pp Cons. · IFRS
FYE Mar 2025 2.4 −1.0pp Cons. · IFRS
FYE Mar 2026 -3.4 −5.7pp Cons. · IFRS
Definition
The share of revenue left after everything
Formula
Net profit ÷ revenue
Source
Securities report (XBRL)

Cost-of-sales ratio

FYE Mar 2026 34.9%
Average · 9 yrs 32.0%
Fiscal year Cost-of-sales ratio % YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 28.0 n/a Cons. · IFRS
FYE Mar 2019 31.1 +3.1pp Cons. · IFRS
FYE Mar 2020 33.1 +2.0pp Cons. · IFRS
FYE Mar 2021 31.1 −2.0pp Cons. · IFRS
FYE Mar 2022 31.0 −0.1pp Cons. · IFRS
FYE Mar 2023 30.9 −0.1pp Cons. · IFRS
FYE Mar 2024 33.5 +2.6pp Cons. · IFRS
FYE Mar 2025 34.5 +1.0pp Cons. · IFRS
FYE Mar 2026 34.9 +0.4pp Cons. · IFRS
Definition
The share of revenue taken by the cost of sales
Formula
Cost of sales ÷ revenue
Source
Securities report (XBRL)

SG&A ratio

FYE Mar 2026 24.1%
Average · 9 yrs 27.7%
Fiscal year SG&A ratio % YoY Basis
FYE Mar 2017 n/a n/a Cons. · IFRS
FYE Mar 2018 35.5 n/a Cons. · IFRS
FYE Mar 2019 34.2 −1.3pp Cons. · IFRS
FYE Mar 2020 29.3 −4.9pp Cons. · IFRS
FYE Mar 2021 27.4 −1.9pp Cons. · IFRS
FYE Mar 2022 24.8 −2.5pp Cons. · IFRS
FYE Mar 2023 24.8 −0.1pp Cons. · IFRS
FYE Mar 2024 24.7 −0.0pp Cons. · IFRS
FYE Mar 2025 24.1 −0.6pp Cons. · IFRS
FYE Mar 2026 24.1 −0.1pp Cons. · IFRS
Definition
The share of revenue taken by selling and administrative costs
Formula
SG&A ÷ revenue
Source
Securities report (XBRL)

Balance sheet Assets, debt and equity, and what they say about financial strength

What the balance sheet is made of

¥ bn
Equity Liabilities and non-controlling interests

Financial strength

%
Equity ratio Debt-to-equity

Total assets

FYE Mar 2026 ¥15.5tn
CAGR · 10 yrs +15.2%
Fiscal year Total assets ¥ bn YoY Basis
FYE Mar 2017 4,347 n/a Cons. · IFRS
FYE Mar 2018 4,106 −5.5% Cons. · IFRS
FYE Mar 2019 13,793 +235.9% Cons. · IFRS
FYE Mar 2020 12,821 −7.0% Cons. · IFRS
FYE Mar 2021 12,912 +0.7% Cons. · IFRS
FYE Mar 2022 13,178 +2.1% Cons. · IFRS
FYE Mar 2023 13,958 +5.9% Cons. · IFRS
FYE Mar 2024 15,109 +8.2% Cons. · IFRS
FYE Mar 2025 14,248 −5.7% Cons. · IFRS
FYE Mar 2026 15,512 +8.9% Cons. · IFRS
Definition
Everything the company holds
Formula
Total assets line of the balance sheet
Source
Securities report (XBRL)

Equity net assets, shareholders' equity

FYE Mar 2026 n/a
CAGR · 9 yrs +17.2%
Fiscal year Equity ¥ bn YoY Basis
FYE Mar 2017 1,949 n/a Cons. · IFRS
FYE Mar 2018 1,997 +2.5% Cons. · IFRS
FYE Mar 2019 5,182 +159.4% Cons. · IFRS
FYE Mar 2020 4,723 −8.8% Cons. · IFRS
FYE Mar 2021 5,173 +9.5% Cons. · IFRS
FYE Mar 2022 5,683 +9.9% Cons. · IFRS
FYE Mar 2023 6,354 +11.8% Cons. · IFRS
FYE Mar 2024 7,273 +14.5% Cons. · IFRS
FYE Mar 2025 6,935 −4.6% Cons. · IFRS
FYE Mar 2026 n/a n/a Cons. · IFRS
Definition
The part of the funding that never has to be repaid
Formula
Net assets line of the balance sheet
Source
Securities report (XBRL)

Interest-bearing debt

FYE Mar 2026 ¥4.88tn
CAGR · 10 yrs +17.5%
Fiscal year Interest-bearing debt ¥ bn YoY Basis
FYE Mar 2017 1,145 n/a Cons. · IFRS
FYE Mar 2018 986 −13.9% Cons. · IFRS
FYE Mar 2019 5,751 +483.5% Cons. · IFRS
FYE Mar 2020 5,093 −11.4% Cons. · IFRS
FYE Mar 2021 4,635 −9.0% Cons. · IFRS
FYE Mar 2022 4,345 −6.3% Cons. · IFRS
FYE Mar 2023 4,382 +0.8% Cons. · IFRS
FYE Mar 2024 4,844 +10.5% Cons. · IFRS
FYE Mar 2025 4,515 −6.8% Cons. · IFRS
FYE Mar 2026 4,882 +8.1% Cons. · IFRS
Definition
Borrowings the company pays interest on
Formula
Loans + bonds + lease obligations
Source
Securities report (XBRL)

Short-term borrowings

FYE Mar 2026 ¥512bn
CAGR · 10 yrs −0.7%
Fiscal year Short-term borrowings ¥ bn YoY Basis
FYE Mar 2017 545 n/a Cons. · IFRS
FYE Mar 2018 0.0 −100.0% Cons. · IFRS
FYE Mar 2019 985 +5471822.2% Cons. · IFRS
FYE Mar 2020 587 −40.4% Cons. · IFRS
FYE Mar 2021 22.2 −96.2% Cons. · IFRS
FYE Mar 2022 204 +820.8% Cons. · IFRS
FYE Mar 2023 340 +66.5% Cons. · IFRS
FYE Mar 2024 367 +8.1% Cons. · IFRS
FYE Mar 2025 549 +49.5% Cons. · IFRS
FYE Mar 2026 512 −6.7% Cons. · IFRS
Definition
Borrowings repayable within a year
Formula
Short-term borrowings line of the balance sheet
Source
Securities report (XBRL)

Long-term borrowings

FYE Mar 2026 ¥4.37tn
CAGR · 10 yrs +24.7%
Fiscal year Long-term borrowings ¥ bn YoY Basis
FYE Mar 2017 600 n/a Cons. · IFRS
FYE Mar 2018 986 +64.3% Cons. · IFRS
FYE Mar 2019 4,766 +383.5% Cons. · IFRS
FYE Mar 2020 4,506 −5.4% Cons. · IFRS
FYE Mar 2021 4,613 +2.4% Cons. · IFRS
FYE Mar 2022 4,141 −10.2% Cons. · IFRS
FYE Mar 2023 4,043 −2.4% Cons. · IFRS
FYE Mar 2024 4,477 +10.7% Cons. · IFRS
FYE Mar 2025 3,966 −11.4% Cons. · IFRS
FYE Mar 2026 4,370 +10.2% Cons. · IFRS
Definition
Borrowings repayable in more than a year
Formula
Long-term borrowings line of the balance sheet
Source
Securities report (XBRL)

Intangible assets

FYE Mar 2026 ¥3.42tn
CAGR · 10 yrs +13.9%
Fiscal year Intangible assets ¥ bn YoY Basis
FYE Mar 2017 1,063 n/a Cons. · IFRS
FYE Mar 2018 1,014 −4.6% Cons. · IFRS
FYE Mar 2019 4,751 +368.4% Cons. · IFRS
FYE Mar 2020 4,171 −12.2% Cons. · IFRS
FYE Mar 2021 3,909 −6.3% Cons. · IFRS
FYE Mar 2022 3,819 −2.3% Cons. · IFRS
FYE Mar 2023 4,270 +11.8% Cons. · IFRS
FYE Mar 2024 4,275 +0.1% Cons. · IFRS
FYE Mar 2025 3,632 −15.0% Cons. · IFRS
FYE Mar 2026 3,419 −5.8% Cons. · IFRS
Definition
Assets with no physical form
Formula
Intangible assets line of the balance sheet
Source
Securities report (XBRL)

Goodwill

FYE Mar 2026 ¥5.81tn
CAGR · 10 yrs +21.3%
Fiscal year Goodwill ¥ bn YoY Basis
FYE Mar 2017 1,020 n/a Cons. · IFRS
FYE Mar 2018 1,029 +0.9% Cons. · IFRS
FYE Mar 2019 4,240 +312.0% Cons. · IFRS
FYE Mar 2020 4,013 −5.4% Cons. · IFRS
FYE Mar 2021 4,034 +0.5% Cons. · IFRS
FYE Mar 2022 4,408 +9.3% Cons. · IFRS
FYE Mar 2023 4,791 +8.7% Cons. · IFRS
FYE Mar 2024 5,410 +12.9% Cons. · IFRS
FYE Mar 2025 5,324 −1.6% Cons. · IFRS
FYE Mar 2026 5,809 +9.1% Cons. · IFRS
Definition
What an acquisition cost above the net assets it brought
Formula
Goodwill line of the balance sheet
Source
Securities report (XBRL)

Equity ratio

FYE Mar 2026 n/a
Average · 9 yrs 43.7%
Fiscal year Equity ratio % YoY Basis
FYE Mar 2017 44.8 n/a Cons. · IFRS
FYE Mar 2018 48.6 +3.8pp Cons. · IFRS
FYE Mar 2019 37.6 −11.1pp Cons. · IFRS
FYE Mar 2020 36.8 −0.7pp Cons. · IFRS
FYE Mar 2021 40.1 +3.2pp Cons. · IFRS
FYE Mar 2022 43.1 +3.1pp Cons. · IFRS
FYE Mar 2023 45.5 +2.4pp Cons. · IFRS
FYE Mar 2024 48.1 +2.6pp Cons. · IFRS
FYE Mar 2025 48.7 +0.5pp Cons. · IFRS
FYE Mar 2026 n/a n/a Cons. · IFRS
Definition
How much of the balance sheet is funded without debt
Formula
Equity ÷ total assets
Source
Securities report (XBRL)

Debt-to-equity ratio D/E ratio

FYE Mar 2026 n/a
Average · 9 yrs 77.1%
Fiscal year Debt-to-equity ratio % YoY Basis
FYE Mar 2017 58.7 n/a Cons. · IFRS
FYE Mar 2018 49.3 −9.4pp Cons. · IFRS
FYE Mar 2019 111.0 +61.6pp Cons. · IFRS
FYE Mar 2020 107.8 −3.2pp Cons. · IFRS
FYE Mar 2021 89.6 −18.2pp Cons. · IFRS
FYE Mar 2022 76.5 −13.1pp Cons. · IFRS
FYE Mar 2023 69.0 −7.5pp Cons. · IFRS
FYE Mar 2024 66.6 −2.4pp Cons. · IFRS
FYE Mar 2025 65.1 −1.5pp Cons. · IFRS
FYE Mar 2026 n/a n/a Cons. · IFRS
Definition
Borrowings measured against the company's own capital
Formula
Interest-bearing debt ÷ equity
Source
Securities report (XBRL)

ROE return on equity

FYE Mar 2026 n/a
Average · 9 yrs 4.3%
Fiscal year ROE % YoY Basis
FYE Mar 2017 5.9 n/a Cons. · IFRS
FYE Mar 2018 9.4 +3.5pp Cons. · IFRS
FYE Mar 2019 2.6 −6.7pp Cons. · IFRS
FYE Mar 2020 0.9 −1.7pp Cons. · IFRS
FYE Mar 2021 7.3 +6.3pp Cons. · IFRS
FYE Mar 2022 4.0 −3.2pp Cons. · IFRS
FYE Mar 2023 5.0 +0.9pp Cons. · IFRS
FYE Mar 2024 2.0 −3.0pp Cons. · IFRS
FYE Mar 2025 1.6 −0.4pp Cons. · IFRS
FYE Mar 2026 n/a n/a Cons. · IFRS
Definition
What the shareholders' capital earns
Formula
Net profit ÷ equity
Source
Securities report (XBRL)

ROA return on assets

FYE Mar 2026 -1.0%
Average · 10 yrs 1.6%
Fiscal year ROA % YoY Basis
FYE Mar 2017 2.6 n/a Cons. · IFRS
FYE Mar 2018 4.6 +1.9pp Cons. · IFRS
FYE Mar 2019 1.0 −3.6pp Cons. · IFRS
FYE Mar 2020 0.3 −0.6pp Cons. · IFRS
FYE Mar 2021 2.9 +2.6pp Cons. · IFRS
FYE Mar 2022 1.7 −1.2pp Cons. · IFRS
FYE Mar 2023 2.3 +0.5pp Cons. · IFRS
FYE Mar 2024 1.0 −1.3pp Cons. · IFRS
FYE Mar 2025 0.8 −0.2pp Cons. · IFRS
FYE Mar 2026 -1.0 −1.7pp Cons. · IFRS
Definition
What the whole balance sheet earns
Formula
Net profit ÷ total assets
Source
Securities report (XBRL)

Asset turnover

FYE Mar 2026 0.29×
CAGR · 10 yrs −3.5%
Fiscal year Asset turnover × YoY Basis
FYE Mar 2017 0.40 n/a Cons. · IFRS
FYE Mar 2018 0.43 +8.2% Cons. · IFRS
FYE Mar 2019 0.15 −64.7% Cons. · IFRS
FYE Mar 2020 0.26 +68.8% Cons. · IFRS
FYE Mar 2021 0.25 −3.5% Cons. · IFRS
FYE Mar 2022 0.27 +9.4% Cons. · IFRS
FYE Mar 2023 0.29 +6.5% Cons. · IFRS
FYE Mar 2024 0.28 −2.2% Cons. · IFRS
FYE Mar 2025 0.32 +13.9% Cons. · IFRS
FYE Mar 2026 0.29 −9.7% Cons. · IFRS
Definition
How much revenue each yen of assets produces
Formula
Revenue ÷ total assets
Source
Securities report (XBRL)

Cash flow statement Cash from operations, investment and financing, and what is left on hand

The three cash flows

¥ bn
Operating CF Investing CF Financing CF

Cash against debt

¥ bn
Cash and equivalents Interest-bearing debt Net cash

Operating cash flow

FYE Mar 2026 ¥1.04tn
CAGR · 10 yrs +16.6%
Fiscal year Operating cash flow ¥ bn YoY Basis
FYE Mar 2017 261 n/a Cons. · IFRS
FYE Mar 2018 378 +44.6% Cons. · IFRS
FYE Mar 2019 328 −13.1% Cons. · IFRS
FYE Mar 2020 670 +103.9% Cons. · IFRS
FYE Mar 2021 1,011 +50.9% Cons. · IFRS
FYE Mar 2022 1,123 +11.1% Cons. · IFRS
FYE Mar 2023 977 −13.0% Cons. · IFRS
FYE Mar 2024 716 −26.7% Cons. · IFRS
FYE Mar 2025 1,057 +47.6% Cons. · IFRS
FYE Mar 2026 1,041 −1.5% Cons. · IFRS
Definition
Cash the business itself generated
Formula
Cash flow from operating activities
Source
Securities report (XBRL)

Investing cash flow

FYE Mar 2026 -¥369bn
Average · 10 yrs -¥490bn
Fiscal year Investing cash flow ¥ bn YoY Basis
FYE Mar 2017 -656 n/a Cons. · IFRS
FYE Mar 2018 -93.3 n/a Cons. · IFRS
FYE Mar 2019 -2,836 n/a Cons. · IFRS
FYE Mar 2020 292 n/a Cons. · IFRS
FYE Mar 2021 394 +34.7% Cons. · IFRS
FYE Mar 2022 -198 −150.3% Cons. · IFRS
FYE Mar 2023 -607 n/a Cons. · IFRS
FYE Mar 2024 -464 n/a Cons. · IFRS
FYE Mar 2025 -367 n/a Cons. · IFRS
FYE Mar 2026 -369 n/a Cons. · IFRS
Definition
Cash spent on, or released by, investment
Formula
Cash flow from investing activities
Source
Securities report (XBRL)

Financing cash flow

FYE Mar 2026 -¥497bn
Average · 10 yrs -¥257bn
Fiscal year Financing cash flow ¥ bn YoY Basis
FYE Mar 2017 290 n/a Cons. · IFRS
FYE Mar 2018 -326 −212.5% Cons. · IFRS
FYE Mar 2019 2,946 n/a Cons. · IFRS
FYE Mar 2020 -1,005 −134.1% Cons. · IFRS
FYE Mar 2021 -1,088 n/a Cons. · IFRS
FYE Mar 2022 -1,070 n/a Cons. · IFRS
FYE Mar 2023 -709 n/a Cons. · IFRS
FYE Mar 2024 -354 n/a Cons. · IFRS
FYE Mar 2025 -751 n/a Cons. · IFRS
FYE Mar 2026 -497 n/a Cons. · IFRS
Definition
Cash raised from, or returned to, lenders and shareholders
Formula
Cash flow from financing activities
Source
Securities report (XBRL)

Cash and equivalents

FYE Mar 2026 ¥595bn
CAGR · 10 yrs +7.2%
Fiscal year Cash and equivalents ¥ bn YoY Basis
FYE Mar 2017 319 n/a Cons. · IFRS
FYE Mar 2018 295 −7.8% Cons. · IFRS
FYE Mar 2019 702 +138.4% Cons. · IFRS
FYE Mar 2020 638 −9.2% Cons. · IFRS
FYE Mar 2021 966 +51.5% Cons. · IFRS
FYE Mar 2022 850 −12.1% Cons. · IFRS
FYE Mar 2023 534 −37.2% Cons. · IFRS
FYE Mar 2024 458 −14.2% Cons. · IFRS
FYE Mar 2025 385 −15.9% Cons. · IFRS
FYE Mar 2026 595 +54.5% Cons. · IFRS
Definition
Cash on hand at the year end
Formula
Closing balance in the cash flow statement
Source
Securities report (XBRL)

Free cash flow

FYE Mar 2026 ¥672bn
Average · 10 yrs ¥266bn
Fiscal year FCF ¥ bn YoY Basis
FYE Mar 2017 -394 n/a Cons. · IFRS
FYE Mar 2018 285 n/a Cons. · IFRS
FYE Mar 2019 -2,507 −981.2% Cons. · IFRS
FYE Mar 2020 962 n/a Cons. · IFRS
FYE Mar 2021 1,404 +46.0% Cons. · IFRS
FYE Mar 2022 925 −34.1% Cons. · IFRS
FYE Mar 2023 370 −60.0% Cons. · IFRS
FYE Mar 2024 252 −31.8% Cons. · IFRS
FYE Mar 2025 690 +173.3% Cons. · IFRS
FYE Mar 2026 672 −2.6% Cons. · IFRS
Definition
What is left once the business has paid for its own investment
Formula
Operating cash flow + investing cash flow
Source
Securities report (XBRL)

Operating cash flow margin

FYE Mar 2026 23.1%
Average · 10 yrs 22.3%
Fiscal year OCF margin % YoY Basis
FYE Mar 2017 15.1 n/a Cons. · IFRS
FYE Mar 2018 21.3 +6.3pp Cons. · IFRS
FYE Mar 2019 15.7 −5.7pp Cons. · IFRS
FYE Mar 2020 20.3 +4.7pp Cons. · IFRS
FYE Mar 2021 31.6 +11.3pp Cons. · IFRS
FYE Mar 2022 31.5 −0.1pp Cons. · IFRS
FYE Mar 2023 24.3 −7.2pp Cons. · IFRS
FYE Mar 2024 16.8 −7.5pp Cons. · IFRS
FYE Mar 2025 23.1 +6.3pp Cons. · IFRS
FYE Mar 2026 23.1 −0.0pp Cons. · IFRS
Definition
How much of the revenue turned into cash
Formula
Operating cash flow ÷ revenue
Source
Securities report (XBRL)

Net cash

FYE Mar 2026 -¥4.29tn
Average · 10 yrs -¥3.48tn
Fiscal year Net cash ¥ bn YoY Basis
FYE Mar 2017 -825 n/a Cons. · IFRS
FYE Mar 2018 -691 n/a Cons. · IFRS
FYE Mar 2019 -5,049 n/a Cons. · IFRS
FYE Mar 2020 -4,456 n/a Cons. · IFRS
FYE Mar 2021 -3,669 n/a Cons. · IFRS
FYE Mar 2022 -3,496 n/a Cons. · IFRS
FYE Mar 2023 -3,849 n/a Cons. · IFRS
FYE Mar 2024 -4,386 n/a Cons. · IFRS
FYE Mar 2025 -4,130 n/a Cons. · IFRS
FYE Mar 2026 -4,287 n/a Cons. · IFRS
Definition
Cash on hand once the borrowings are paid off
Formula
Cash and equivalents − interest-bearing debt
Source
Securities report (XBRL)

Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples

Market capitalisation

FYE Mar 2026 n/a
Change · 9 yrs +¥2.90tn
Fiscal year Market capitalisation ¥ bn Basis
FYE Mar 2017 4,130 n/a
FYE Mar 2018 4,128 n/a
FYE Mar 2019 7,086 n/a
FYE Mar 2020 5,213 n/a
FYE Mar 2021 6,299 n/a
FYE Mar 2022 5,541 n/a
FYE Mar 2023 6,885 n/a
FYE Mar 2024 6,616 n/a
FYE Mar 2025 7,026 n/a
FYE Mar 2026 n/a n/a
Definition
What the market says the company is worth
Formula
Year-end share price × shares outstanding
Source
Securities report (XBRL)

Share price year-end close

FYE Mar 2026 n/a
Change · 9 yrs −808¥
Fiscal year Share price ¥ Basis
FYE Mar 2017 5,224 n/a
FYE Mar 2018 5,194 n/a
FYE Mar 2019 4,528 n/a
FYE Mar 2020 3,307 n/a
FYE Mar 2021 3,996 n/a
FYE Mar 2022 3,502 n/a
FYE Mar 2023 4,351 n/a
FYE Mar 2024 4,181 n/a
FYE Mar 2025 4,416 n/a
FYE Mar 2026 n/a n/a
Definition
The closing price on the last day of the fiscal year
Formula
Year-end closing price
Source
Securities report (XBRL)

Shares outstanding

FYE Mar 2026 1,591,229,000shares
Change · 10 yrs +800,708,000 shares
Fiscal year Shares outstanding shares Basis
FYE Mar 2017 790,521,000 Parent
FYE Mar 2018 794,688,000 Parent
FYE Mar 2019 1,565,006,000 Parent
FYE Mar 2020 1,576,374,000 Parent
FYE Mar 2021 1,576,388,000 Parent
FYE Mar 2022 1,582,253,000 Parent
FYE Mar 2023 1,582,296,000 Parent
FYE Mar 2024 1,582,419,000 Parent
FYE Mar 2025 1,590,950,000 Parent
FYE Mar 2026 1,591,229,000 Parent
Definition
How many shares exist
Formula
Shares issued, from the key figures of the filing
Source
Securities report (XBRL)

EPS earnings per share

FYE Mar 2026 -96.75¥
Change · 10 yrs −243.90¥
Fiscal year EPS ¥ Basis
FYE Mar 2017 147.15 Cons.
FYE Mar 2018 239.35 Cons.
FYE Mar 2019 140.61 Cons.
FYE Mar 2020 28.41 Cons.
FYE Mar 2021 240.72 Cons.
FYE Mar 2022 147.14 Cons.
FYE Mar 2023 204.29 Cons.
FYE Mar 2024 92.09 Cons.
FYE Mar 2025 68.36 Cons.
FYE Mar 2026 -96.75 Cons.
Definition
Net profit for each share
Formula
Net profit ÷ average shares outstanding
Source
Securities report (XBRL)

BPS book value per share

FYE Mar 2026 n/a
Change · 9 yrs +1,893.67¥
Fiscal year BPS ¥ Basis
FYE Mar 2017 2,465.42 Cons. · IFRS
FYE Mar 2018 2,513.47 Cons. · IFRS
FYE Mar 2019 3,311.16 Cons. · IFRS
FYE Mar 2020 2,996.42 Cons. · IFRS
FYE Mar 2021 3,281.58 Cons. · IFRS
FYE Mar 2022 3,591.73 Cons. · IFRS
FYE Mar 2023 4,015.76 Cons. · IFRS
FYE Mar 2024 4,596.29 Cons. · IFRS
FYE Mar 2025 4,359.08 Cons. · IFRS
FYE Mar 2026 n/a Cons. · IFRS
Definition
Equity behind each share
Formula
Equity ÷ shares outstanding
Source
Securities report (XBRL)

PER price-to-earnings ratio

FYE Mar 2026 n/a
Average · 9 yrs 41.94×
Fiscal year PER × Basis
FYE Mar 2017 35.50 Cons.
FYE Mar 2018 21.70 Cons.
FYE Mar 2019 32.20 Cons.
FYE Mar 2020 116.40 Cons.
FYE Mar 2021 16.60 Cons.
FYE Mar 2022 23.80 Cons.
FYE Mar 2023 21.30 Cons.
FYE Mar 2024 45.40 Cons.
FYE Mar 2025 64.60 Cons.
FYE Mar 2026 n/a Cons.
Definition
How many years of earnings the price stands for
Formula
Year-end price ÷ EPS
Source
Securities report (XBRL)

PBR price-to-book ratio

FYE Mar 2026 n/a
Average · 9 yrs 1.31×
Fiscal year PBR × Basis
FYE Mar 2017 2.15 Cons.
FYE Mar 2018 2.03 Cons.
FYE Mar 2019 1.36 Cons.
FYE Mar 2020 1.09 Cons.
FYE Mar 2021 1.21 Cons.
FYE Mar 2022 0.96 Cons.
FYE Mar 2023 1.06 Cons.
FYE Mar 2024 0.90 Cons.
FYE Mar 2025 1.00 Cons.
FYE Mar 2026 n/a Cons.
Definition
The price measured against the book value behind it
Formula
Year-end price ÷ BPS
Source
Securities report (XBRL)

Workforce and productivity Headcount, pay and what each employee accounts for

Group employees

FYE Mar 2026 47,029people
Change · 10 yrs +17,129 people
Fiscal year Group employees people YoY Basis
FYE Mar 2017 29,900 n/a Cons.
FYE Mar 2018 27,230 −8.9% Cons.
FYE Mar 2019 49,578 +82.1% Cons.
FYE Mar 2020 47,495 −4.2% Cons.
FYE Mar 2021 47,099 −0.8% Cons.
FYE Mar 2022 47,347 +0.5% Cons.
FYE Mar 2023 49,095 +3.7% Cons.
FYE Mar 2024 49,281 +0.4% Cons.
FYE Mar 2025 47,455 −3.7% Cons.
FYE Mar 2026 47,029 −0.9% Cons.
Definition
Everyone employed across the group
Formula
Consolidated headcount, from the employee section of the filing
Source
Securities report (XBRL)

Parent-company employees

FYE Mar 2026 4,792people
Change · 10 yrs −1,846 people
Fiscal year Parent-company employees people YoY Basis
FYE Mar 2017 6,638 n/a Parent
FYE Mar 2018 5,461 −17.7% Parent
FYE Mar 2019 5,291 −3.1% Parent
FYE Mar 2020 5,350 +1.1% Parent
FYE Mar 2021 4,966 −7.2% Parent
FYE Mar 2022 5,149 +3.7% Parent
FYE Mar 2023 5,486 +6.5% Parent
FYE Mar 2024 5,474 −0.2% Parent
FYE Mar 2025 4,808 −12.2% Parent
FYE Mar 2026 4,792 −0.3% Parent
Definition
Employees of the filing company itself
Formula
Parent-only headcount, from the employee section of the filing
Source
Securities report (XBRL)

Average annual pay parent company

FYE Mar 2026 ¥11.4m
Change · 10 yrs +¥1.3m
Fiscal year Average annual pay ¥ m YoY Basis
FYE Mar 2017 10.2 n/a Parent
FYE Mar 2018 10.4 +2.3% Parent
FYE Mar 2019 10.9 +5.3% Parent
FYE Mar 2020 10.9 −0.3% Parent
FYE Mar 2021 10.8 −1.3% Parent
FYE Mar 2022 11.1 +2.6% Parent
FYE Mar 2023 11.0 −0.7% Parent
FYE Mar 2024 10.8 −1.4% Parent
FYE Mar 2025 11.0 +2.1% Parent
FYE Mar 2026 11.4 +3.7% Parent
Definition
Average total annual compensation, bonuses included
Formula
Average annual pay, from the employee section of the filing
Source
Securities report (XBRL)

Average age

FYE Mar 2026 44.0years
Change · 8 yrs +2.5 years
Fiscal year Average age years YoY Basis
FYE Mar 2017 n/a n/a Parent
FYE Mar 2018 n/a n/a Parent
FYE Mar 2019 41.5 n/a Parent
FYE Mar 2020 42.2 +1.7% Parent
FYE Mar 2021 42.0 −0.5% Parent
FYE Mar 2022 42.4 +1.0% Parent
FYE Mar 2023 42.8 +0.9% Parent
FYE Mar 2024 43.3 +1.2% Parent
FYE Mar 2025 43.4 +0.2% Parent
FYE Mar 2026 44.0 +1.4% Parent
Definition
Average age of the parent company's employees
Formula
Average age, from the employee section of the filing
Source
Securities report (XBRL)

Average length of service

FYE Mar 2026 14.8years
Change · 10 yrs +0.1 years
Fiscal year Average length of service years YoY Basis
FYE Mar 2017 14.7 n/a Parent
FYE Mar 2018 14.5 −1.4% Parent
FYE Mar 2019 15.1 +4.1% Parent
FYE Mar 2020 15.0 −0.7% Parent
FYE Mar 2021 14.5 −3.3% Parent
FYE Mar 2022 14.2 −2.1% Parent
FYE Mar 2023 14.0 −1.4% Parent
FYE Mar 2024 14.6 +4.3% Parent
FYE Mar 2025 14.4 −1.4% Parent
FYE Mar 2026 14.8 +2.8% Parent
Definition
How long the average employee has been with the company
Formula
Average years of service, from the employee section of the filing
Source
Securities report (XBRL)

Revenue per employee

FYE Mar 2026 ¥95.8m
Change · 10 yrs +¥37.9m
Fiscal year Revenue per employee ¥ m YoY Basis
FYE Mar 2017 57.9 n/a Cons.
FYE Mar 2018 65.0 +12.2% Cons.
FYE Mar 2019 42.3 −34.9% Cons.
FYE Mar 2020 69.3 +63.8% Cons.
FYE Mar 2021 67.9 −2.0% Cons.
FYE Mar 2022 75.4 +11.0% Cons.
FYE Mar 2023 82.0 +8.8% Cons.
FYE Mar 2024 86.5 +5.5% Cons.
FYE Mar 2025 96.5 +11.6% Cons.
FYE Mar 2026 95.8 −0.8% Cons.
Definition
What each employee accounts for in revenue
Formula
Revenue ÷ group employees
Source
Securities report (XBRL)

Operating profit per employee

FYE Mar 2026 ¥0.1m
Change · 9 yrs −¥8.7m
Fiscal year OP per employee ¥ m YoY Basis
FYE Mar 2017 n/a n/a Cons.
FYE Mar 2018 8.9 n/a Cons.
FYE Mar 2019 4.8 −46.0% Cons.
FYE Mar 2020 2.1 −55.9% Cons.
FYE Mar 2021 10.8 +411.5% Cons.
FYE Mar 2022 9.7 −10.0% Cons.
FYE Mar 2023 10.0 +2.6% Cons.
FYE Mar 2024 4.3 −56.5% Cons.
FYE Mar 2025 7.2 +66.2% Cons.
FYE Mar 2026 0.1 −98.2% Cons.
Definition
What each employee accounts for in operating profit
Formula
Operating profit ÷ group employees
Source
Securities report (XBRL)

Disclaimer

Accuracy, liability, reuse and privacy — the full disclaimer →

Data API

Takeda Pharmaceutical’s history, presidents and financials are published as static JSON — no key, plain GET. One API per public page, and one per section where a page carries several tables. Full specification →

/api/4502/company.json ·/api/4502/history.json ·/api/4502/ceo.json ·/api/4502/financials.json ·/api/4502/financials/segment.json ·/api/4502/financials/pl.json ·/api/4502/financials/cf.json ·/api/4502/financials/bs.json ·/api/4502/financials/employee.json ·/api/4502/financials/stock.json ·/api/4502/financials.csv ·/api/4502/financials_history.csv

/api/companies.json ·/api/decisions.json ·/api/api-manifest.json